LAAO and the Watchman FLX; HF Care in Private Equity Hospitals; Long-term Outcomes in TR and Mitral Valve-in-Valve Replacement

In this week’s View, Dr. Eagle looks at the lower risk of major adverse events in patients with left atrial appendage occlusion (LAAO) using the Watchman 2.4 device. He then discusses the impact of heart failure (HF) care in private equity hospitals in the United States. Finally, Dr. Eagle explores the long-term outcomes of patients with tricuspid regurgitation (TR) undergoing mitral valve-in-valve (MViV) replacement. 

 Subscribe to Eagle’s Eye View